LeadingStockAlerts.com provides free stock reports for investors and day traders, simply by going to LeadingStockAlerts.com or by going to the link below, you can see all the daily information on Nuvilex, Inc (OTC:NVLX). As a of 3:59pm July 31, traded at $0.14 with a daily range between $0.1402 and $0.1685.
Nuvilex opened higher than the previous day’s close at 0.17. The Company has a market cap of 67.59 million. Their volume is 4,435,430 with an three month average volume of 3,398,260. The 52 week range is wide, between 0.02 and 0.22, so the Company is not far from the year’s peak.
You can get more information from your free stock report by going to leadingstockalerts.com or by going to the window below.
On Wednesday, the Company announced that its medical marijuana segment could mirror the success Israel had. In fact, Goldman Small Cap Research noted that considering the success of some of the Israeli programs in treating cancer patients with cannabis, Nuvilex may mimic some of their initiatives.
About LeadingStockAlerts
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Many small cap and micro cap companies lack the recognition required to raise the resources needed to increase equity appreciation and liquidity. This community has traditionally been shunned by Wall Street Institutions and has been forced to look elsewhere for exposure.This site understands that there are many explosive companies waiting to be discovered by the retail investment community. These firms do not have the technology or time to introduce themselves to a wide range of potential investors. Our site allows its clients to focus on achieving their business goals while taking over the task of introducing the company to millions of potential investors.
